Literature DB >> 17716994

Colorectal polypectomy and risk of colorectal cancer by subsite: the Fukuoka Colorectal Cancer study.

Daigo Yoshida1, Suminori Kono, Malcolm A Moore, Kengo Toyomura, Jun Nagano, Tetsuya Mizoue, Ryuichi Mibu, Masao Tanaka, Yoshihiro Kakeji, Yoshihiko Maehara, Takeshi Okamura, Koji Ikejiri, Kitaroh Futami, Yohichi Yasunami, Takafumi Maekawa, Kenji Takenaka, Hitoshi Ichimiya, Nobutoshi Imaizumi.   

Abstract

BACKGROUND: Colorectal adenomas are well-established precursor lesions for colorectal cancer and removal of polyps is deemed to reduce the risk of colorectal cancer. However, benefit of colorectal polypectomy in routine practice is still uncertain. We therefore investigated subsite-specific risks of colorectal cancer in relation to history of colorectal polypectomy in a case-control study.
METHODS: Both case patients and control subjects were residents aged 20-74 years in Fukuoka City and three adjacent areas. The case group comprised 840 patients undergoing surgery for a first diagnosis of colorectal cancer, while the control subjects were 833 residents who were selected in the community by two-stage random sampling. Past history of selected diseases, surgery and lifestyle factors were ascertained by in-person interview. Statistical adjustment was made for sex, 5-year age class, residence, smoking, alcohol drinking, physical activity, body mass index and parental history of colorectal cancer.
RESULTS: Overall, 74 case patients (9%) and 85 control subjects (10%) reported a prior history of colorectal polyps, and 50 cases (6%) and 64 controls (8%) had a history of colorectal polypectomy. The adjusted odds ratio associated with colorectal polypectomy was 0.71 (95% confidence interval [CI] 0.48-1.06) for the overall risk of colorectal cancer. The corresponding values for cancer of the proximal colon, distal colon, and rectum were 1.68 (95% CI 0.98-2.88), 0.71 (95% CI 0.41-1.26) and 0.24 (95% CI 0.11-0.52), respectively.
CONCLUSIONS: The findings indicate that colorectal polypectomy in current practice confers a decreased risk of rectal cancer and possibly of distal colon cancer.

Entities:  

Mesh:

Year:  2007        PMID: 17716994     DOI: 10.1093/jjco/hym065

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  5 in total

1.  Expression profile of the REG gene family in colorectal carcinoma.

Authors:  Hua-chuan Zheng; Akira Sugawara; Hiroshi Okamoto; Shin Takasawa; Hiroyuki Takahashi; Shinji Masuda; Yasuo Takano
Journal:  J Histochem Cytochem       Date:  2011-01       Impact factor: 2.479

2.  Up-regulated EMMPRIN/CD147 protein expression might play a role in colorectal carcinogenesis and its subsequent progression without an alteration of its glycosylation and mRNA level.

Authors:  Hua-chuan Zheng; Wei Wang; Xiao-yan Xu; Pu Xia; Miao Yu; Toshiro Sugiyama; Yasuo Takano
Journal:  J Cancer Res Clin Oncol       Date:  2010-06-01       Impact factor: 4.553

3.  Korean guidelines for postpolypectomy colonoscopy surveillance.

Authors:  Dong-Hoon Yang; Sung Noh Hong; Young-Ho Kim; Sung Pil Hong; Sung Jae Shin; Seong-Eun Kim; Bo In Lee; Suck-Ho Lee; Dong Il Park; Hyun-Soo Kim; Suk-Kyun Yang; Hyo Jong Kim; Se Hyung Kim; Hyun Jung Kim
Journal:  Clin Endosc       Date:  2012-03-31

4.  Downregulated inhibitor of growth 3 (ING3) expression during colorectal carcinogenesis.

Authors:  Wen-feng Gou; Hong-zhi Sun; Shuang Zhao; Zhe-feng Niu; Xiao-Yun Mao; Yasuo Takano; Hua-chuan Zheng
Journal:  Indian J Med Res       Date:  2014-04       Impact factor: 2.375

5.  Colorectal cancer in cases of multiple primary cancers: Clinical features of 59 cases and point mutation analyses.

Authors:  Anshan Wu; Siqi He; Jingjing Li; Ling Liu; Chunlan Liu; Qi Wang; Xiaowei Peng; Jianda Zhou; Pei-Guo Cao; Ke Cao
Journal:  Oncol Lett       Date:  2017-04-26       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.